Legal status: Not FDA-approved for human use Sold as a "research chemical" Legal to buy and possess in most countries Widely used despite research-only labeling What BPC-157 does in your body The mechanism is elegantly simple
The compound is the subject of ongoing late-stage investigational programmes, including combinations with semaglutide
Given that BPC-157 appears to promote angiogenesis (new blood vessel formation) the same process that can feed tumor growth the lack of dedicated cancer-safety studies is a genuine gap, not a technicality
Treatment is often recommended when deficiency is confirmed
Patients with isolated tendon or ligament injuries, post-surgical recovery needs, NSAID-related gut concerns, or chronic musculoskeletal inflammation tend to respond best
Why Researchers Are Watching Cagrilintide The most significant area of current Cagrilintide research involves its combination potential with GLP-1 agonists